Estimate Recalculated May 19, 2025 08:11PM EST
Deerfield Mgmt IV, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DFP HEALTHCARE ACQUISITIONS CORP., Nkarta, Inc., Revolution Medicines, Inc., Singular Genomics Systems, Inc., Edgewise Therapeutics, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., ARVINAS INC., Schrodinger, Inc., AdaptHealth Corp., Larimar Therapeutics, Inc., PROTEON THERAPEUTICS INC, Cabaletta Bio, Inc., Annexon, Inc., Frequency Therapeutics, Inc., and ARS Pharmaceuticals, Inc..
Deerfield Mgmt IV, L.P.'s CIK is 0001713467
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!